Why the study?
Does a high loading dose of clopidogrel improve inhibition of platelet aggregation compared to standard clopidogrel or ticlopidine in patients undergoing coronary stent placement?
Does a high loading dose of clopidogrel improve inhibition of platelet aggregation compared to standard clopidogrel or ticlopidine in patients undergoing coronary stent placement?
Answers are grounded in this paper and cite their sources.
A 600 mg loading dose of clopidogrel achieves faster and more potent inhibition of platelet aggregation than a 300 mg loading dose or ticlopidine in patients undergoing coronary stenting.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Andrew Thorns (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: